Physician profile
Khalid Iqbal
NPI 1447349329
$605.12
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $309 · 2020: $258 · 2021: $37.90.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $134.69 | 2019-2021 | |
| Amarin Pharma, INC. | $95.88 | 2019-2021 | |
| Novo Nordisk INC | $56.65 | 2019-2020 | |
| Glaxosmithkline, LLC. | $50.30 | 2019 | |
| Sunovion Pharmaceuticals INC. | $50.06 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.78 | 2019-2020 | |
| Lilly USA, LLC | $36.60 | 2019-2020 | |
| Radius Health, INC. | $28.88 | 2020 | |
| Pfizer INC. | $27.22 | 2020 | |
| Janssen Pharmaceuticals, INC | $27.03 | 2019-2020 | |
| Amgen INC. | $19.36 | 2019 | |
| Evoke Pharma, INC. | $16.01 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $12.50 | 2020 | |
| Astellas Pharma US INC | $11.16 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalid Iqbal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.